Search
Close this search box.

Clinical Trial: ECOG-ACRIN EA6174

ECOG-ACRIN EA6174

Status: Temporarily Closed

STAMP: Surgically Treated Adjuvant Merkel cell carcinoma with Pembrolizumab, a Phase III Trial

Eligible for screening study DCP 001

EA6174 is temporarily closed to accrual, effective March 31, 2023.